331 related articles for article (PubMed ID: 32979440)
1. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
3. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
4. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
[TBL] [Abstract][Full Text] [Related]
5. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
7. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment.
Ahmad N; Al-Subaiec AM; Ahmad R; Sharma S; Alam MA; Ashafaq M; Abdur Rub R; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):475-490. PubMed ID: 30739499
[TBL] [Abstract][Full Text] [Related]
8. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ
Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
[TBL] [Abstract][Full Text] [Related]
10. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
12. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
14. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
15. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
Zhou W; Wang Y; Jian J; Song S
Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
[TBL] [Abstract][Full Text] [Related]
16. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
17. Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Dhuri A; Sriram A; Aalhate M; Mahajan S; Parida KK; Singh H; Gupta U; Maji I; Guru SK; Singh PK
Pharm Dev Technol; 2023 Jun; 28(5):460-478. PubMed ID: 37092801
[TBL] [Abstract][Full Text] [Related]
18. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
[TBL] [Abstract][Full Text] [Related]
19. Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.
Soliman NM; Shakeel F; Haq N; Alanazi FK; Alshehri S; Bayomi M; Alenazi ASM; Alsarra IA
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889340
[TBL] [Abstract][Full Text] [Related]
20. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]